Product Name :
UF010, HDAC Inhibitor
Description:
UF-010 is a Class I HDAC inhibitor (IC50 values are 0.06, 0.1, 0.5 and 1.5 μM for HDACs 3, 2, 1 and 8, respectively). UF010 inhibits cancer cell proliferation via class I HDAC inhibition. This causes global changes in protein acetylation and gene expression, resulting in activation of tumor suppressor pathways and concurrent inhibition of several oncogenic pathways. The isotype selectivity coupled with interesting biological activities in suppressing tumor cell proliferation support further preclinical development of the UF010 class of compounds for potential therapeutic applications.
CAS:
537672-41-6
Molecular Weight:
271.{{Pibrentasvir} MedChemExpress|{Pibrentasvir} Anti-infection|{Pibrentasvir} Biological Activity|{Pibrentasvir} In stock|{Pibrentasvir} manufacturer|{Pibrentasvir} Epigenetic Reader Domain} 15
Formula:
C11H15BrN2O
Chemical Name:
4-bromo-N’-butylbenzohydrazide
Smiles :
CCCCNNC(=O)C1C=CC(Br)=CC=1
InChiKey:
BVQCFCYPFJOOAV-UHFFFAOYSA-N
InChi :
InChI=1S/C11H15BrN2O/c1-2-3-8-13-14-11(15)9-4-6-10(12)7-5-9/h4-7,13H,2-3,8H2,1H3,(H,14,15)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{E 2012} site|{E 2012} Neuronal Signaling|{E 2012} Protocol|{E 2012} In Vivo|{E 2012} manufacturer|{E 2012} Autophagy}
Shelf Life:
≥12 months if stored properly.PMID:34856019
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
UF-010 is a Class I HDAC inhibitor (IC50 values are 0.06, 0.1, 0.5 and 1.5 μM for HDACs 3, 2, 1 and 8, respectively). UF010 inhibits cancer cell proliferation via class I HDAC inhibition. This causes global changes in protein acetylation and gene expression, resulting in activation of tumor suppressor pathways and concurrent inhibition of several oncogenic pathways. The isotype selectivity coupled with interesting biological activities in suppressing tumor cell proliferation support further preclinical development of the UF010 class of compounds for potential therapeutic applications.|Product information|CAS Number: 537672-41-6|Molecular Weight: 271.15|Formula: C11H15BrN2O|Chemical Name: 4-bromo-N’-butylbenzohydrazide|Smiles: CCCCNNC(=O)C1C=CC(Br)=CC=1|InChiKey: BVQCFCYPFJOOAV-UHFFFAOYSA-N|InChi: InChI=1S/C11H15BrN2O/c1-2-3-8-13-14-11(15)9-4-6-10(12)7-5-9/h4-7,13H,2-3,8H2,1H3,(H,14,15)|Technical Data|Appearance: Solid Power.|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO up to 100 mM|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined.|HS Tariff Code: 382200|How to use|In Vitro:|UF010 was used at 5-10 µM final concentration in vitro and in cellular assays.|References:|Wang Y, et al. Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases. (2015) Chem Biol. 22(2):273-84.Products are for research use only. Not for human use.|Documents||